Qiang Wei

14PUBLICATIONS
8CO-AUTHORS
Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Cancer diagnosisMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 21, 2026
Non-contrast CT radiomics for identifying nonfunctioning kidneys: a multicenter development and external validation study.

|Aug 17, 2026
A comprehensive framework for multi-class prostate cancer classification using biparametric MRI: a multi-center retrospective study.

|May 29, 2026
Ferroptosis vulnerability of enzalutamide resistant prostate cancer conferred by ACSL4 overexpression and GPX4 antagonism.

|Mar 26, 2026
SMARCA4 promotes lineage plasticity and enzalutamide resistance in prostate cancer by regulating PROX1 via H3K27 acetylation.

Chenwei Wu, Mayao Luo, Chaojian Wu

|Feb 27, 2026
UHRF1 regulates AR ubiquitination to promote the loss of AR signaling and enzalutamide resistance in progression of prostate cancer.

Yifan Zhang, Zhaojun Yu, Yadong Li

|Nov 17, 2025
Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression.

Haoran Wen, Maierhaba Maheremu, Kaidi Zhang

Pageof 3

Frequent Collaborators

4 joint publications

Yifan Zhang

3 joint publications

Hailiang Hu

1 joint publications

Zhou Wang

1 joint publications

Shidong Lv